Cantor Fitzgerald Bumps Price Target on Expedia (EXPE) to $70
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts EXPE Hot Sheet
Price: $274.22 +1.51%
Rating Summary:
22 Buy, 37 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
22 Buy, 37 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Cantor Fitzgerald reiterated its Buy rating and raised its price target on Expedia (NASDAQ: EXPE) from $67 to $70.
The firm said checks show robust growth in paid clicks for Expedia.com in Oct./Nov., indicating that the site continues to see improved traffic conversion and ROI.
"With hotel trends relatively unchanged (Q/Q) across the U.S. and Europe and a limited hit from Hurricane Sandy, we believe this should translate into healthy double-digit growth in hotel room-nights and revenue in 4Q."
For an analyst ratings summary and ratings history on Expedia click here. For more ratings news on Expedia click here.
Shares of Expedia closed at $58.99 yesterday.
The firm said checks show robust growth in paid clicks for Expedia.com in Oct./Nov., indicating that the site continues to see improved traffic conversion and ROI.
"With hotel trends relatively unchanged (Q/Q) across the U.S. and Europe and a limited hit from Hurricane Sandy, we believe this should translate into healthy double-digit growth in hotel room-nights and revenue in 4Q."
For an analyst ratings summary and ratings history on Expedia click here. For more ratings news on Expedia click here.
Shares of Expedia closed at $58.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva Pharma (TEVA) PT Raised to $52 at Oppenheimer
- Amrize Ltd (AMRZ) PT Lowered to $40 at DA Davidson as FY26 Guidance 'at Risk'
- Owens Corning (OC) PT Lowered to $143 at DA Davidson
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
